Violation Tracker Individual Record
Company:TAP Pharmaceutical Products, Inc.
Date:May 25, 2006
Offense Group:competition-related offenses
Primary Offense:kickbacks and bribery
TAP Pharmaceutical Products agreed to pay $798,000 to settle allegations of fraudulent marketing practices which included improperly influencing doctors to prescribe the high-priced cancer drug, Lupron.
Level of Government:state
Action Type:agency action
Agency:Wisconsin Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:Japan
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.